Nucs AI provides AI-driven software for detection, prediction, and monitoring in theranostics and molecular imaging, specifically focused on prostate cancer care. The platform analyzes PSMA-PET/CT scans to identify tumors, predict treatment outcomes, and evaluate treatment response, delivering results in under a minute with 92% accuracy in identifying PSMA-positive lesions.
2024
Healthcare, Medical Imaging, Oncology
v